Skip to main content

Table 1 Overview of receiving immunotherapy dataset information

From: Genomic and immunogenomic analysis of three prognostic signature genes in LUAD

Treatment response

Number

Data sets

Medication regimen

Pathological type

non-responder (SD and PD)

19

GEO:GSE135222

Immunotherapy

Lung non-small cell carcinoma

responder (CR and PR)

8

GEO:GSE135222

anti-PD-1/PD-L1

Lung non-small cell carcinoma

non-responder (SD and PD)

6

GEO:GSE126044

Nivolumab

Lung squamous cell carcinoma

non-responder (SD and PD)

5

GEO:GSE126044

Nivolumab

LUAD

responder (CR and PR)

3

GEO:GSE126044

Nivolumab

Lung squamous cell carcinoma

responder (CR and PR)

2

GEO:GSE126044

Nivolumab

LUAD

  1. CR complete response, PR partial response, SD stable disease, PD progressive disease